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The mcr-1 (mobile colistin resistance 1) gene, which en-
codes phosphoethanolamine transferase, has been recent-
ly identified as a source of acquired resistance to polymyx-
ins in Escherichia coli. Using the SuperPolymyxin selective 
medium, we prospectively screened 100 pigs at 2 farms in 
Portugal for polymyxin-resistant Enterobacteriaceae and 
recovered 98 plasmid-mediated MCR-1–producing iso-
lates. Most isolates corresponded to nonclonally related E. 
coli belonging to many sequence types; we also found 2 
Klebsiella pneumoniae sequence types. The mcr-1 gene 
was carried on IncHI2 or IncP plasmid backbones. Our find-
ing of a high rate of MCR-1 producers on 2 pig farms in 
Portugal highlights the diffusion of that colistin-resistance 
determinant at the farm level. The fact that the pigs received 
colistin as metaphylaxis in their feed during the 6 weeks 
before sampling suggests selective pressure.
The progressive global increase of antimicrobial drug resistance in Enterobacteriaceae is worrisome, and 
adding to the concern is the recent discovery of the plas-
mid-mediated mobile colistin resistance (MCR) genes 
mcr-1 and mcr-2 (1,2). These genes encode phosphoetha-
nolamine transferases, which add a phosphoethanolamine 
group to the lipid A of the lipopolysaccharide, leading to 
gram-negative bacteria resistance to polymyxins (3). Since 
its discovery, the mcr-1 gene has been identified almost 
worldwide, mostly in animal and environmental samples 
(3) and to a lesser extent in human clinical samples (4). 
The mcr-1 gene has often been identified from Escherichia 
coli strains recovered from pigs (3,5–8). More recently, the 
mcr-2 gene, which shares 76.8% nt identity with mcr-1, has 
been identified from a single E. coli isolate recovered from 
a pig in Belgium (2). The genetic element related to the 
mcr-2 gene and possibly involved in its acquisition is inser-
tion sequence (IS) ISEc69.
The mcr-1 gene has been identified on a large variety 
of plasmids, such as IncI2, IncX4, IncHI2, IncP, IncFI, In-
cFII, IncFIB, and IncY (3,9,10). The genetic context of the 
mcr-1 gene always includes the mcr-1 cassette, as previ-
ously described (11,12). In addition, ISApl1 is often found 
upstream of the mcr-1 gene. It has been recently shown that 
a second copy of ISApl1 may be found downstream of the 
mcr-1 gene, therefore bracketing the 2.6-kb mcr-1 cassette 
and forming the composite transposon Tn6330, demon-
strated to be functional and responsible for the transposi-
tion of mcr-1 (13,14).
We speculate that the emergence and further dissemi-
nation of the mcr-1 and -2 genes occurred from pigs and 
that ISApl and ISEc69, respectively, were the main genetic 
elements involved in that process. We recently demonstrat-
ed that Moraxella spp. are sources of mcr-like encoding 
genes (15); M. pluranimalium has been identified as the 
progenitor of the mcr-2 gene (16). Of note, all Moraxella 
spp. are widespread in pigs (17), thus allowing specula-
tion that the whole genetic process that originally led to the 
emergence of the mcr-like genes occurred in those animals.
Worldwide, colistin is widely used in veterinary medi-
cine for different purposes, including treatment of enteric 
infections, prophylaxis or metaphylaxis (18), and as growth 
promoter in several countries (19). Despite this selective 
pressure, studies reporting identification of colistin-resis-
tant Enterobacteriaceae in veterinary medicine remain 
scarce, although an overall low prevalence of those resis-
tant strains was noticed in Europe (8,10,20,21).
To evaluate the prevalence and genetic characteriza-
tion of colistin-resistant Enterobacteriaceae on pig farms, 
we performed a prospective epidemiologic survey. The 
study was conducted in Portugal (the fifth largest polymyx-
in consumer in Europe), where colistin is heavily used in 
veterinary medicine (22).
Materials and Methods
Isolates and Susceptibility Testing
On 1 day in June 2016, we collected 100 rectal swab sam-
ples from pigs on 2 pig farms in Portugal, 30 km apart. 
These farms, harboring ≈3,000 pigs each, are production 
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holdings, where piglets are born and fattened before being 
delivered to slaughterhouses (23). All pigs sampled were 
10–11 weeks of age. When the pigs were 5–10 weeks of 
age, their feed included colistin (0.5%), amoxicillin (0.5%), 
and zinc oxide (0.15%). The weekly dose of colistin in the 
regimen was ≈0.06 g/kg. Overall, all pigs received ≈5.5 g 
colistin for metaphylaxis over 6 weeks.
We incubated rectal swab samples overnight at 37°C 
in Luria-Bertani broth supplemented with 1 µg/mL co-
listin. The next day, to select for colistin-resistant gram-
negative isolates, we inoculated each enrichment tube onto 
SuperPolymyxin selective agar medium that contained 
3.5 µg/mL colistin and 10 µg/mL daptomycin (ELITech-
Group, Signes, France) (24). We identified colistin-resis-
tant isolates recovered from SuperPolymyxin plates with 
API 20E (bioMérieux, La Balme les Grottes, France). 
We performed antimicrobial drug susceptibility testing 
by using the disk-diffusion method according to Clinical 
and Laboratory Standards Institute recommendations, on 
Muller-Hinton agar plates, except for colistin, for which 
we evaluated MICs for colistin by broth microdilution in 
cation-adjusted Muller-Hinton broth (Bio-Rad, Cressier, 
Switzerland), as recommended by the Clinical and Labora-
tory Standards Institute (25).
Molecular Analyses
Acquired colistin-resistance genes mcr-1 and mcr-2 were 
identified by PCR, with use of specific primers as reported 
(14), and amplicons were further sequenced by Microsynth 
(Balgach, Switzerland). We identified extended-spectrum 
β-lactamase (ESBL)–encoding genes by using primers 
specific for detection of blaTEM, blaSHV, and blaCTX-M genes 
(26,27). The plasmidborne chloramphenicol gene floR was 
sought by using specific primers (28) among isolates exhib-
iting resistance to chloramphenicol. The clonal relationship 
of the colistin-resistant isolates was evaluated by pulsed-
field gel electrophoresis, as described previously (29), and 
multilocus sequence typing was performed for a represen-
tative strain of each pulsotype. We assigned sequence types 
(STs) by using the multilocus sequence typing databases 
for E. coli (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli) and 
K. pneumoniae (http://bigsdb.pasteur.fr/klebsiella/klebsi-
ella.html). The phylogenetic group of E. coli isolates was 
determined with the PCR-based Clermont method as de-
scribed previously (30).
Conjugation Experiments and Plasmid Analyses
We performed conjugation assays on filters with azide-re-
sistant E. coli J53 as the recipient strain. MCR-1 producers 
and the J53 isolate were cultured overnight in Luria-Bertani 
broth. To reach the logarithmic phase, the donor and recipi-
ent strains were subcultured in fresh Luria-Bertani broth 
for 3 h. We subsequently mixed the samples at a ratio of 
10:1 and deposited 100 µL of this mix onto 22-µm filters, 
which we then incubated for 5 h at 37°C on Luria-Bertani 
agar plates. After the incubation, filters were resuspended 
in 0.85% NaCl, and we plated 250 µL of this mixture onto 
selective Luria-Bertani plates containing azide (100 µg/
mL) and colistin (1 µg/mL). PCR was used to check all E. 
coli transconjugants for the mcr-1 gene.
We typed plasmids carrying the mcr-1 gene from E. 
coli transconjugants by using the PCR-based replicon typ-
ing method (31). The size of the plasmid was obtained after 
Kieser extraction (32) and agarose gel electrophoresis; we 
used as a reference E. coli 50192 isolate containing 4 char-
acterized plasmids (154 kb, 66 kb, 48 kb, and 7 kb).
Results
From the 100 rectal swab samples collected, we recovered 
108 colistin-resistant isolates from the SuperPolymyxin 
agar plates and identified 90 as E. coli, 17 as K. pneumoni-
ae, and 1 as Proteus mirabilis. Of the 108 colistin-resistant 
isolates, 98 were positive for the mcr-1 gene. Colistin MICs 
for all MCR-1–producing isolates ranged from 4 to 32 µg/
mL (Table). Among these positive isolates, 10 showed an 
ESBL phenotype. Sequencing revealed that all mcr-posi-
tive isolates possessed a gene that was 100% identical to 
mcr-1. All MCR-1–producing isolates possessed the bla-
TEM-1 gene, and all ESBL producers possessed the blaCTX-
M-2 gene. All MCR-1–producing isolates were resistant to 
penicillins and tetracycline, 97.9% were resistant to sulfa-
methoxazole/trimethoprim, 96% were resistant to tobramy-
cin, and 84.7% were resistant to chloramphenicol. Among 
the chloramphenicol-resistant isolates, 56% were positive 
for the floR resistance gene. No mcr-2–positive isolate was 
identified in our samples.
Pulsed-field gel electrophoresis identified 19 distinct E. 
coli clones from the first farm sampled and 18 from the sec-
ond (Table). The isolates belonged to 15 STs (ST10, ST23, 
ST38, ST46, ST101, ST156, ST6453, and 8 new STs); only 
2 (ST10 and ST101) were detected on both farms. Phyloge-
netic typing showed that each E. coli isolate belonged to 1 
of the phylogroups A, B1, C, D, E, or F. No extraintestinal 
and virulent B2 phylogroup was detected among all E. coli 
isolates. In addition, we identified 2 K. pneumoniae STs (1 
clone per farm), ST45 and ST1563.
Conjugation followed by PCR-based replicon typing 
analysis showed that the mcr-1 gene was carried on different 
plasmids (Table). The mcr-1 gene was identified on IncHI2 
(54%), IncP (38%), and IncX4 (8%) plasmids. Conjugation 
experiments showed that resistance to sulfamethoxazole/
trimethoprim and sulfonamides was systematically co-trans-
ferred along with the mcr-1 gene when carried by IncHI2 
plasmids and that resistance to tetracycline, tobramycin, 
chloramphenicol, and amoxicillin was also most often co-
transferred by IncP plasmids (Table). Conversely, the mcr-1 
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Table. Genetic features associated with MCR-1–producing Escherichia coli and Klebsiella pneumoniae isolates from pigs, Portugal* 
Strain Species 
No. 





group (kb) of 




Farm 1         
 P13 E. coli 6 ST101 blaCTX-M-2, blaTEM-1, 
mcr-1 
4 IncHI2 (250) SXT/TET/NAL/AMX/CTX/TMN/
SUL 
II 
 P8 E. coli 1 ST101 blaCTX-M-2, blaTEM-1, 
mcr-1, floR 
4 IncHI2 (250) SXT/TET/AMX/CTX/TMN/SUL II 
 P28 E. coli 4 New ST1 blaTEM-1, mcr-1, floR 8 IncHI2 (250) SXT/TET/CHL/AMX/TMN/GMN
/SUL 
II 
 P11 E. coli 1 New ST2 blaTEM-1, mcr-1, floR 16 IncHI2 (250) SXT/TET/CHL/AMX/TMN/SUL III 
 P4 E. coli 3 New ST1 blaTEM-1, mcr-1 16 IncP (60) TET/ CHL /AMX/TMN/SUL II 
 P9 E. coli 1 New ST2 blaTEM-1, mcr-1 16 IncP (60) TET/CHL/AMX/TMN/SUL II 
 P27 E. coli 1 ST6453 blaTEM-1, mcr-1 16 IncP (60) TET/CHL/AMX/TMN/SUL I 
 P7 E. coli 1 New ST2 blaTEM-1, mcr-1 16 IncP (60) TET/CHL/AMX/TMN/SUL II 
 P43 E. coli 1 New ST4 blaTEM-1, mcr-1 16 IncP (60) TET/CHL/AMX/TMN//GMN III 
 P10 E. coli 1 ST10 blaTEM-1, mcr-1 16 IncHI2 (250) TET/ CHL /AMX/TMN/SUL II 
 P5 E. coli 1 New ST4 blaTEM-1, mcr-1 8 IncP (60) TET/ CHL /AMX/TMN/SUL II 
 P1 E. coli 1 New ST3 blaTEM-1, mcr-1 8 IncP (60) TET/ CHL /AMX/TMN/SUL II 
 P2 E. coli 1 New ST2 blaTEM-1, mcr-1 8 IncP (60) SXT/TET/CHL/AMX/TMN/SUL II 
 P16 E. coli 1 ST10 blaTEM-1, mcr-1 8 IncX4(30) SXT/TET/AMX/TMN/SUL III 
 P3 E. coli 5 ST156 blaTEM-1, mcr-1 8 IncHI2 (250) SXT/TET/NAL/CIP/AMX/TMN/
SUL 
I 
 P20 E. coli 1 New ST2 blaTEM-1, mcr-1 4 IncHI2 (~250) SXT/TET/AMX/TMN/SUL III 
 P22 E. coli 13 ST6453 blaTEM-1, mcr-1 4 IncP (60) TET/AMX/TMN/SUL I 
 P19 E. coli 1 New ST4 blaTEM-1, mcr-1 4 IncP (60) SXT/TET/ 
CHL/NAL/AMX/TMN/SUL 
II 
 P37 E. coli 1 ST38 blaTEM-1, mcr-1 4 IncP (60) SXT/TET/AMX/TMN/SUL I 
 P6K K. 
pneumoniae 
6 ST45 blaTEM-1, mcr-1 32 IncP (60) TET/AMX/TMN/SUL II 
Farm 2         
 B21 E. coli 1 ST10 blaTEM-1, mcr-1, floR 16 IncHI2 (250) SXT/CHL/TET/NAL/CIP/AMX/T
MN/SUL 
III 
 B12 E. coli 8 ST10 blaTEM-1, mcr-1, floR 16 IncHI2 (250) SXT/CHL/TET/NAL/CIP/AMX/T
MN/SUL 
III 
 B30 E. coli 10 ST10 blaTEM-1, mcr-1, floR 16 IncHI2 (250) SXT/CHL/TET/NAL/CIP/AMX/T
MN/SUL 
III 
 B3 E. coli 1 New ST6 blaTEM-1, mcr-1, floR 16 IncHI2 (250) SXT/CHL/TET/NAL/AMX/TMN/
SUL 
I 
 B27 E. coli 1 New ST7 blaTEM-1, mcr-1, floR 16 IncHI2 (250) CHL/TET/NAL/CIP/AMX/TMN/
SUL 
I 
 B47 E. coli 1 New ST7 blaTEM-1, mcr-1, floR 16 IncHI2 (250) SXT/CHL/TET/AMX/TMN/SUL III 
 B18 E. coli 2 New ST8 blaTEM-1, mcr-1, floR 16 IncX4 (30) SXT/CHL/TET/AMX/TMN/SUL III 
 B22 E. coli 5 New ST8 blaTEM-1, mcr-1, floR 16 IncHI2 (250) SXT/CHL/TET/AMX/TMN/SUL II 
 B4 E. coli 1 New ST7 blaTEM-1, mcr-1, floR 16 IncHI2 (250) SXT/CHL/TET/AMX/TMN/SUL III 
 B15 E. coli 1 ST46 blaTEM-1, mcr-1, floR 8 IncHI2 (250) SXT/CHL/TET/AMX/TMN/SUL III 
 B6 E. coli 2 ST101 blaTEM-1, mcr-1, floR 8 IncHI2 (250) SXT/CHL/TET/AMX/TMN/SUL III 
 B8 E. coli 1 New ST6 blaTEM-1, mcr-1, floR 8 IncX4 (30) SXT/CHL/TET/NAL/AMX/TMN/
SUL 
III 
 B1 E. coli 1 New ST6 blaTEM-1, mcr-1, floR 8 IncHI2 (250) SXT/CHL/TET/AMX/TMN/SUL III 
 B11 E. coli 1 New ST7 blaTEM-1, mcr-1, floR 8 IncHI2 (250) CHL//TET/NAL/AMX/TMN/SUL IV 
 B9 E. coli 9 ST23 blaTEM-1, mcr-1, floR 4 IncP (60) SXT/CHL/TET/NAL/AMX/TMN/
SUL 
II 
 B5 E. coli 1 New ST8 blaTEM-1, mcr-1, floR 4 IncP (60) SXT/CHL/TET/NAL/AMX/TMN/
SUL 
III 
 B27K K. 
pneumoniae 
2 ST1563 blaTEM-1, mcr-1, floR 32 IncHI2 (250) SXT/CHL/TET/AMX/TMN/SUL I 
*Only strains representative of each pulsed-field gel electrophoresis clonal lineage are listed. AMX, amoxicillin; CIP, ciprofloxacin, CHL, chloramphenicol; 
CTX, cefotaxime; NAL, nalidixic acid; ND, not determined; ST, sequence type; SUL, sulfonamides; SXT, sulfamethoxazole/trimethoprim; TET, 
tetracycline; TMN, tobramycin. 
†STs were identified with the Warwick University database (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli). Because this database accepts only whole-genome 
sequencing data to submit new STs, all new STs found were notified as New STx. 
‡Underlining indicates co-resistances provided by the plasmid carrying mcr-1. 
§Different genetic environments detected by PCR, as shown in the Figure. 
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gene was the only resistance determinant when located on 
IncX4 plasmids. Of note, IncP-type plasmids carrying mcr-1 
were predominant on the first farm, whereas IncHI2 plas-
mids were predominant on the second farm.
By PCR mapping using previously published prim-
ers (12,13), in all isolates we identified the ≈2.6-kb mcr-1 
cassette in association with 0, 1, or 2 copies of insertion 
sequence ISApl1, depending on the isolates tested (Table; 
Figure). In addition, we found a genetic structure not pre-
viously reported in 1 isolate that consisted of a truncated 
ISApl1 element upstream of the mcr-1 cassette. That struc-
ture, inserted into a kinase gene onto an IncHI2 plasmid, 
corresponded to a truncated version of transposon Tn6330 
previously reported, with a 2-bp AG direct repeat bracket-
ing the ∆ISApl1-mcr-1 structure, suggesting a former inser-
tion event through a transposition mechanism (Figure).
Discussion
Prevalence of MCR-1–producing Enterobacteriacae iso-
lates, mainly E. coli, from 2 pig farms in Portugal was 
high. So far, the mcr-1 gene has been identified mainly 
in animal samples, rarely in environmental and human 
samples (3,4,33–36). Previous studies describe the occur-
rence of MCR-1 producers in swine; prevalence in Europe 
ranged from 0.5% to 13.5% (6,8,36,37) and in China up 
to 20.6% (1). In our study, we detected an extremely high 
rate of MCR-1–producing Enterobacteriaceae, finding the 
mcr-1 gene in isolates from 98% of pigs tested. We identi-
fied an MCR-1–producing K. pneumoniae among the pigs, 
which is noteworthy considering the infrequent recovery 
of K. pneumoniae from animals. Nevertheless, most of the 
mcr-1–positive isolates identified here were E. coli, as is re-
ported in most epidemiologic studies (3). For the same pigs 
that had been screened (by nasal swabs) for methicillin-
resistant Staphylococcus aureus, the rate of colonization 
was very high (99%); 2 main spa types of clone ST398 
were identified (23).
Our study was performed with samples from pigs, and 
it would be of interest to conduct similar studies of humans. 
In France, a survey performed in a hospital during Febru-
ary–May 2016 (38) showed a high rate (23%) of fecal car-
riage with intrinsic colistin-resistant gram-negative isolates 
but a low rate (1.4%) of acquired polymyxin resistance; no 
mcr-1 or mcr-2 genes were identified. A retrospective study 
focusing on Salmonella isolates was previously performed 
in Portugal, and MCR-1 producers were reportedly found 
in humans and pork (39). No MCR-2–producing isolate 
was identified in our study, although this gene was also 
identified in pigs (2).
We used the newly developed SuperPolymyxin me-
dium for our prospective epidemiologic study. The fact 
that no colistin-susceptible strain was recovered during 
the screening further highlights the excellent specificity 
of this medium. 
Unexpectedly, we found that the studied collection of 
MCR-1 producers was highly diverse; we identified many 
STs and genetic features associated with mcr-1. The rate 
of mcr-1 in our study was very high and caused by the dis-
semination of neither a single clone nor a plasmid. This 
high diversity could be explained by 2 key elements. First, 
considering that the selective pre-enrichment with Luria-
Bertani broth supplemented with 1 µg/mL of colistin and 
subsequent culturing on the Superpolymyxin medium ex-
hibits a high sensitivity, such a prospective survey may 
detect higher rates of colistin-resistant isolates than would 
previous studies. Second, the presence of colistin in the pig 
food on the 2 farms studied probably represents an efficient 
selective pressure for MCR-1 acquisition. Findings of simi-
lar and comparative studies performed in countries that do 
not use polymyxins in animals, such as Norway or Finland, 
would be of interest.
Several STs of E. coli identified in this study were sim-
ilar to those of other MCR-1–producing isolates reported 
from other studies. As an example, ST10 E. coli producing 
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Figure. Genetic environments 
associated with the mcr-1 
(mobile colistin resistance 
1) gene detected in select 
Enterobacteriacae isolates from 
pigs, Portugal, by PCR. I) 1 copy 
of ISApl1 associated with mcr-1 
in 5′ region; II) 2 copies of ISApl1 
in 5′ and 3′ regions of mcr-1; III) 
no copy of ISApl1 associated 
with mcr-1; IV) truncated copy 
of ISApl1 associated with mcr-1 
in 5′ region inserted in a kinase 
gene. IS, insertion sequence; orf, 
open reading frame.
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MCR-1 was recovered from swine farms in Germany and 
in clinical samples in India and South Africa (6,11,40). 
In South Africa, ST101 E. coli was identified from a pa-
tient with a urinary tract infection (11). ST156 E. coli was 
identified at a hospital in China and in a muscovy duck in 
China, where it was co-producing MCR-1 and NDM (New 
Delhi metallo-β-lactamase)–5 carbapenemase (41,42). We 
showed that all E. coli isolates belonged to a commensal 
population and not to extraintestinal pathogenic strains, 
which is consistent with findings of other studies (3) and in 
line with the design of our study, which was analyzing the 
colonizing gut flora.
We showed that the mcr-1 gene was carried by a di-
versity of plasmids. However, most plasmids recovered 
from the first farm were ≈60-kb IncP plasmids, whereas 
those from the second farm were ≈250-kb IncHI2 plas-
mids. Only 3 STs possessed a ≈30-kb IncX4 plasmid car-
rying the mcr-1 gene, which contrasts with other studies 
that have shown this type of plasmid to be predominant 
(43). In accordance with what has been observed with 
other characterized IncX4 plasmids, we found no other 
resistant determinant associated with mcr-1 on that plas-
mid type. IncP and IncHI2 plasmids carried other resis-
tance determinants associated with mcr-1. Remarkably, 
we found no IncI2-type plasmid carrying mcr-1 in those 
isolates, although they have often been reported in the lit-
erature (1,3).
Analysis of the genetic features associated with the 
mcr-1 gene further highlights that it was probably original-
ly acquired by a transposition mechanism and that ISApl1 
played a major role; further truncations or rearrangements 
led to the stabilization of this structure, as suggested by 
Snesrud et al. (44). We also identified the entire composite 
transposon Tn6330 comprising 2 copies of ISApl1 bracket-
ing the mcr-1 cassette (13). Because this entire transposon 
was detected in some isolates of this collection in addition 
to other defective versions of it, we can speculate that this 
structure may still be mobilizable and continue to dissemi-
nate between different genetic locations.
In summary, the rate of pig colonization with MCR-1–
producing Enterobacteriaceae was high at the 2 farms we 
sampled, showing substantial diversity of species, clonal-
ity, and genetic aspects. Even if these results suggest that 
colistin constitutes a major driving force for selecting plas-
mids carrying the mcr-1 gene, the occurrence of the blaTEM-1 
gene on the same plasmid indicates that β-lactams might 
also be co-selecting for colistin resistance through the ac-
quisition of such plasmids. In addition, this study showed 
that SuperPolymyxin is an efficient medium for screening 
colistin-resistant isolates from animal samples and per-
forming such epidemiologic surveys. Last, considering 
that a recent report from Germany identified pig farms 
as potential sources of environmental contamination for 
MCR-1–producing E. coli (6), our data strongly indicate 
the need for screening farm environments in Portugal, to 
evaluate the extent to which the spread of those resistant 
bacteria has already occurred and, therefore, to better mea-
sure the risk to human health.
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Johann Goeze is credited with the first correct description of Taenia [Latin, “flat band” or “ribbon”] saginata [Latin, “fed”], commonly 
known as the beef tapeworm, in 1782. Historically, Taenia tapeworms 
were believed to have infected humans no more than 10,000 years ago, 
around the time of domestication of cows and pigs.
However, more recent phylogenetic evidence suggests that ances-
tors of modern humans, living on the savannahs of Africa and preying 
on antelope and other bovids, became colonized with Taenia >3 mil-
lion years ago. Parasite definitive hosts switched from large carnivores 
(probably hyenas) to hominids through their common prey, and this 
process triggered the evolution of human-infecting species of Taenia. 
Humans later spread these parasites to domestic animals.
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